disopyramide has been researched along with Urination Disorders in 8 studies
Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.
Urination Disorders: Abnormalities in the process of URINE voiding, including bladder control, frequency of URINATION, as well as the volume and composition of URINE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Searle), literature demonstrating its efficacy in maintaining uniform serum drug levels over a 12-h dosing interval is derived from only normal healthy volunteers." | 1.27 | Serum drug concentrations and adverse effects in cardiac patients after administration of a new controlled-release disopyramide preparation. ( Zema, MJ, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsuchishita, Y | 1 |
| Fukumoto, K | 1 |
| Kusumoto, M | 1 |
| Ueno, K | 1 |
| Alves, LE | 1 |
| Rose, EP | 1 |
| Cahill, TB | 1 |
| Hai, HA | 1 |
| Danziger, LH | 1 |
| Horn, JR | 1 |
| Zema, MJ | 1 |
| Kaji, T | 1 |
| Nojima, Y | 1 |
| Arisaka, H | 1 |
| Naruse, T | 1 |
| Gavaghan, TP | 1 |
| Feneley, MP | 1 |
| Campbell, TJ | 1 |
| Morgan, JJ | 1 |
| Teichman, S | 1 |
| Navas, P | 1 |
| Grasset, D | 1 |
2 trials available for disopyramide and Urination Disorders
| Article | Year |
|---|---|
Clinical pharmacokinetics and effects of an oral sustained-release preparation of disopyramide prescribed for patients undergoing maintenance hemodialysis.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined | 2000 |
The anticholinergic side effects of disopyramide and controlled-release disopyramide.
Topics: Delayed-Action Preparations; Disopyramide; Drug Interactions; Drug Therapy, Combination; Humans; Pyr | 1985 |
6 other studies available for disopyramide and Urination Disorders
| Article | Year |
|---|---|
Effects of serum concentrations of disopyramide and its metabolite mono-N-dealkyldisopyramide on the anticholinergic side effects associated with disopyramide.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Autonomic Nervous System Diseases; Chromatography, High Pressur | 2008 |
Disopyramide-induced urinary retention.
Topics: Aged; Disopyramide; Female; Humans; Middle Aged; Parasympatholytics; Urination Disorders | 1984 |
Disopyramide-induced urinary retention. Report of nine cases and review of the literature.
Topics: Aged; Disopyramide; Humans; Male; Pyridines; Urination Disorders | 1983 |
Serum drug concentrations and adverse effects in cardiac patients after administration of a new controlled-release disopyramide preparation.
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Delayed-Action Preparations; Diarrhea; Diso | 1984 |
Atrial tachyarrhythmias after cardiac surgery: results of disopyramide therapy.
Topics: Atrial Fibrillation; Atrial Flutter; Cardiac Surgical Procedures; Digoxin; Disopyramide; Drug Therap | 1985 |
[Proceedings: Total bladder retention caused by treatment of cardiac arrhythmias with Rythmodan].
Topics: Anti-Arrhythmia Agents; Disopyramide; Humans; Male; Middle Aged; Muscle, Smooth; Pyridines; Urinatio | 1973 |